Multi-Agent Portfolio

# MAP Post-Market — 2026-10-08

## Snapshot
- Valor total: $9,728.20; P&L del día: $-33.62; retorno desde inception: -2.718%.
- Cash: $3,334.38 (34.3%); deliberadamente alto, sin obligación de full deploy.

## Mercado
- SPY: $773.93; retorno desde inception +0.086%; alpha MAP -2.804 pp.
- El tape fue mixto: SPY avanzó 0.56% en 5 días, pero hoy el book sufrió especialmente en ZYME y AMZN/LLY.
- Sin breakouts confirmados con volumen en los nombres principales; se priorizó disciplina de entrada.

## Acciones ejecutadas
- SELL ZYME, 5.02 acciones a $25.26 (~$126.81): Risk detectó deterioro severo de crecimiento/margen y breakdown técnico.
- Sin BUY/ADD: los vetos de Risk bloquearon entradas, y no se fuerza reemplazo.

## Contexto para mañana
- Mantener el núcleo; esperar confirmación de breakout con volumen o reparación técnica.
- Vigilar JPM antes del evento de resultados del 13-oct y la resistencia cercana de XOM/V.

# MAP Debate — 2026-10-08

## Ronda 1 y Ronda 2
- Sentiment: narrativa constructiva pero sin catalizador suficiente para perseguir; scout ideas con claims de X fueron tratadas como no verificadas.
- Quant: MSFT y XOM fueron los setups relativos más firmes, pero sin breakout confirmado; GOOGL, AMZN, JPM, LLY, BRK-B y V quedaron en zona de chop/repair.
- Fundamental: calidad alta en MSFT, GOOGL, AMZN, LLY, V y BRK-B; ZYME mostró deterioro extremo. Los nombres scouts sin datos duros no calificaron.
- Cross-debate: la calidad fundamental no anuló la falta de confirmación técnica ni el riesgo de chase.

## Risk
- Veto absoluto a nuevas compras/adiciones en todos los tickers revisados; cash mínimo respetado.
- SELL ZYME por revenue growth -90.6%, margen 0%, flujo libre negativo y breakdown debajo de MA20.

# MAP Decisions — 2026-10-08

## Fórmula
CS = 0.40 Quant + 0.35 Fundamental + 0.25 Sentiment. BUY >= 0.70, WATCHLIST >= 0.50, PASS < 0.50 o veto.

## Scorecard
- **MSFT** — CS 0.7200 (Quant 0.64 / Fund 0.84 / Sent 0.68) → **PASS** · veto: VETO new BUY/ADD: RSI 70.51, price 2.442% below resistance, sub-1x volume (0.879x), and no confirmed 20-day breakout; AI/fundamental quality does not justify chasing or increasing correlated mega-cap exposure.
- **XOM** — CS 0.6540 (Quant 0.60 / Fund 0.69 / Sent 0.69) → **PASS** · veto: VETO new BUY/ADD: strongest held-stock trend but price is only 0.637% below resistance, breakout is false, and the +2.749% day came on 0.986x volume; commodity cyclicality adds reversal risk.
- **GOOGL** — CS 0.6375 (Quant 0.42 / Fund 0.87 / Sent 0.66) → **PASS** · veto: VETO new BUY/ADD: strong fundamentals but choppy structure, 0.805x volume, and no breakout confirmation; avoid adding to crowded mega-cap exposure until price confirms.
- **AMZN** — CS 0.6185 (Quant 0.41 / Fund 0.82 / Sent 0.67) → **PASS** · veto: VETO new BUY/ADD: choppy tape, -2.255% day, RSI 50.44, and no breakout; reported growth and institutional ownership are not sufficient timing evidence.
- **V** — CS 0.6060 (Quant 0.43 / Fund 0.79 / Sent 0.63) → **PASS** · veto: VETO new BUY/ADD: price is 0.549% below resistance with no breakout confirmation; positive five-day performance and quality fundamentals do not justify adding into a stalled setup.
- **LLY** — CS 0.6050 (Quant 0.43 / Fund 0.78 / Sent 0.64) → **PASS** · veto: VETO new BUY/ADD: high-quality growth but -1.581% day, no breakout, and price 3.709% below resistance; elevated valuation and product/pipeline concentration reduce margin for timing error.
- **BRK-B** — CS 0.6005 (Quant 0.43 / Fund 0.76 / Sent 0.65) → **PASS** · veto: VETO new BUY/ADD: stable diversifier but no volume-backed breakout and price remains 2.413% below resistance; preserve financial-sector balance rather than increase correlated exposure.
- **JPM** — CS 0.5195 (Quant 0.43 / Fund 0.55 / Sent 0.62) → **PASS** · veto: VETO new BUY/ADD: price is 2.26% below MA20 with RSI 30.2 and support only 2.211% below; earnings on 2026-10-13 create near-term binary event risk despite attractive valuation.
- **PENG** — CS 0.3370 (Quant 0.09 / Fund 0.56 / Sent 0.42) → **PASS** · veto: VETO BUY: post-earnings extension is extreme at +30.175% over five days, 27.246% above MA20, RSI 77.41, and no breakout; negative free cash flow, 114.455 debt/equity, and unverified guidance add fundamental risk.
- **CLF** — CS 0.3225 (Quant 0.50 / Fund 0.00 / Sent 0.49) → **PASS** · veto: VETO BUY: orderly technical setup but no breakout confirmation, 7.018% resistance gap, negative margin, and cyclical steel exposure; watch only until hard confirmation improves.
- **ZIM** — CS 0.3025 (Quant 0.30 / Fund 0.00 / Sent 0.73) → **PASS** · veto: VETO BUY: missing hard price, volume, RSI, support/resistance, and operating metrics; guidance increase is summarized X discourse and depends on cyclical freight rates, so risk cannot size an entry.
- **RXO** — CS 0.2160 (Quant 0.07 / Fund 0.28 / Sent 0.36) → **PASS** · veto: VETO BUY: acquisition chase with unverified terms, +35.44% five-day gain, 32.203% above MA20, RSI 89.02, near resistance, weak profitability, and closing/integration risk.
- **ZYME** — CS 0.2115 (Quant 0.18 / Fund 0.22 / Sent 0.25) → **PASS** · veto: VETO all new BUY/ADD: revenue growth -90.6%, zero margin, negative free cash flow, -4.787% day, below-MA20 breakdown structure, and only 0.879% above support. Existing exposure is speculative and no longer merits automatic maintenance.

## Decisión
- No hubo BUY ni ADD. Se ejecutó SELL del residual ZYME; el cash liberado queda sin reinvertir hasta que aparezca edge confirmado.